The global tissue engineered skin substitute market is set to grow steadily, with its valuation projected to rise from USD 2.4 billion in 2024 to USD 3.5 billion by 2034, at a compound annual growth rate (CAGR) of 3.9% during the forecast period. This growth is driven by advancements in regenerative medicine, increasing demand for …